--- title: "Curapath: Resource Library" description: GMP LNP formulations, non-viral delivery, PNPs, GMP polymer and lipid excipients, and Curapath’s end-to-end CDMO capabilities and PEG Alternatives. image: https://resources.curapath.com/hubfs/Captura%20de%20pantalla%202025-06-19%20073551-1.png --- [![White](https://resources.curapath.com/hs-fs/hubfs/White.png?width=1063&height=400&name=White.png "White")](https://curapath.com/) # Resource **Library** # Products --- ![\_2025 Product catalog CURAPATH-v2511](https://resources.curapath.com/hs-fs/hubfs/_2025%20%20Product%20catalog%20CURAPATH-v2511.png?width=316&height=447&name=_2025%20%20Product%20catalog%20CURAPATH-v2511.png) Discover our products ## Product Catalog **Discover Curapath's cutting-edge offerings in our catalog. Explore our LNP and PNP components, as well as our polymer conjugates, all designed to advance drug delivery. Enhance your research and development with our high-quality products**. [Download](https://20205171.hs-sites.com/en/curapath-product-catalog?hsLang=en) ![Captura de pantalla 2026-02-20 093050](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantalla%202026-02-20%20093050.png?width=316&height=445&name=Captura%20de%20pantalla%202026-02-20%20093050.png) Discover our Featured products ## Featured Products Catalog **Discover Curapath's featured products catalog, a curated selection of advanced excipients and delivery components ready to accelerate your formulation programs.** [Download](https://resources.curapath.com/featured-products-catalog?hsLang=en) ![Shileding lipids for tLNPs](https://resources.curapath.com/hs-fs/hubfs/clicr%20cat%20portada.png?width=316&height=442&name=clicr%20cat%20portada.png) solutions for Active Targeting ## Active Targeting Shielding Lipids **Discover CliCr®-modified shielding lipids designed to enhance functionalization density, maintain particle integrity, and enable targeted delivery to T cells, lung, brain, and beyond , available from R&D to GMP-ready scale.** [Download](https://resources.curapath.com/active-targeting-shielding-lipids-for-lnp-development?hsLang=en) # Brochures & Case Studies --- ![Captura de pantalla 2026-06-25 104706-1](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantalla%202026-06-25%20104706-1.png?width=300&height=390&name=Captura%20de%20pantalla%202026-06-25%20104706-1.png) ## Lung-Targeted LNP Development (Case Study)  Explore how next‑generation **lung‑targeted LNPs** leverage **PEG‑free PSar shielding** and **CliCr® conjugation** to enable efficient ligand attachment, overcome liver tropism, and achieve selective pulmonary delivery with minimal impact on core LNP properties.  [Download](https://resources.curapath.com/tlnp-development-lung-case-study?hsLang=en) ![Solutions for Active Targeting (1).pptx](https://resources.curapath.com/hs-fs/hubfs/Solutions%20for%20Active%20Targeting%20(1).pptx.png?width=316&height=447&name=Solutions%20for%20Active%20Targeting%20(1).pptx.png) ## Solutions For Active Targeting: Application Note  Explore how surface functionalization transforms LNPs into precise, receptor‑guided delivery systems for RNA therapeutics.  [Download](https://resources.curapath.com/active-targeting-solutions?hsLang=en) ![PEG- Free Shielding Lipids 2026-1](https://resources.curapath.com/hs-fs/hubfs/PEG-%20Free%20Shielding%20Lipids%202026-1.jpg?width=316&height=446&name=PEG-%20Free%20Shielding%20Lipids%202026-1.jpg) ## PEG-Free Shielding Lipids  Explore how PEG‑free shielding lipids enhance LNP stability, circulation, and targeting while overcoming PEG‑related limitations to enable more flexible and effective RNA delivery. [Download](https://resources.curapath.com/peg-free-shielding-lipids?hsLang=en) ![Def Curapath CDMO-3.pdf](https://resources.curapath.com/hs-fs/hubfs/Def%20Curapath%20CDMO-3.pdf.jpg?width=316&height=447&name=Def%20Curapath%20CDMO-3.pdf.jpg) ## CDMO Services  This leaflet outlines Curapath’s lipid- and polymer-based CDMO platform for advanced drug delivery, covering drug substance and drug product development, analytical services, GMP manufacturing, and sterile Fill & Finish capabilities.  [Download](https://resources.curapath.com/cdmo-services-brochure?hsLang=en) ![Captura de pantalla 2025-12-01 101716](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantalla%202025-12-01%20101716.png?width=316&height=449&name=Captura%20de%20pantalla%202025-12-01%20101716.png) ## Biologics Solubilizer  Discover how our PSar-based solubilizing agent enhances biologic stability and solubility, outperforming polysorbates as a safe, scalable next-generation excipient. [Download](https://resources.curapath.com/psar-solubilizer-biologics?hsLang=en) ![Captura de pantalla 2025-09-18 085047](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantalla%202025-09-18%20085047.png?width=316&height=445&name=Captura%20de%20pantalla%202025-09-18%20085047.png) ## PLGA/PLA API encapsulation Scalable PLA/PLGA nanoparticle packages for peptides and small molecules: formulation, QC, and release studies.Cost effective solutions for complex drug delivery challeges [Download](https://resources.curapath.com/plga-nanoparticles-formulation-packagespla-?hsLang=en) ![Formulation Development Services MA (1)](https://resources.curapath.com/hs-fs/hubfs/Formulation%20Development%20Services%20%20MA%20(1).png?width=316&height=447&name=Formulation%20Development%20Services%20%20MA%20(1).png) ## Formulation Development Services Discover Curapath’s Essential, Advanced, and Expert formulation packages for LNP & PNP systems, flexible, cost-effective solutions for drug delivery development. [Download](https://resources.curapath.com/en/curapath-formulation-development-packages?hsLang=en) ![curapath-certest](https://resources.curapath.com/hs-fs/hubfs/curapath-certest.png?width=340&height=443&name=curapath-certest.png) ## Next generation Lipid Nanoparticle (LNPs) formulation Certest and Curapath have joined forces to develop a novel LNP formulation leveraging the complementary Benefits of their proprietary excipients [Download](https://resources.curapath.com/en/curapath-curapath-certest-next-generation-lnps?hsLang=en) ![Captura de pantalla 2026-09-16 100820](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantalla%202026-09-16%20100820.png?width=340&height=484&name=Captura%20de%20pantalla%202026-09-16%20100820.png) ## Polymer-Drug Conjugates Case Study Optimization, Scale-up, and GMP Manufacturing of a Polymer-Drug Conjugate for Parenteral Administration [Download](https://resources.curapath.com/gmp-manufacturing-polymer-drug-conjugate?hsLang=en) ![App Note Knauer Screenshot](https://resources.curapath.com/hs-fs/hubfs/App%20Note%20Knauer%20Screenshot.png?width=340&height=492&name=App%20Note%20Knauer%20Screenshot.png) ## NanoScaler Pro Application Note Implementation of IJM NanoScaler Pro: Automated screening system for lipid nanoparticle formulation [Download](https://resources.curapath.com/en/curapath-nanoscaler-pro-app-note?hsLang=en) ![LNP Formulation process Technical App Digital (2)\_Página\_1](https://resources.curapath.com/hs-fs/hubfs/LNP%20Formulation%20process%20Technical%20App%20Digital%20(2)_P%C3%A1gina_1.png?width=340&height=481&name=LNP%20Formulation%20process%20Technical%20App%20Digital%20(2)_P%C3%A1gina_1.png) ## LNP Formulation & Process Development for GMP Manufacturing Explore how lipid nanoparticles (LNPs) are formulated, purified, and scaled for mRNA delivery, from microfluidic mixing to TFF purification and GMP-ready production. [Download](https://resources.curapath.com/en/lnp-formulation-processdevelopment?hsLang=en) ![Captura de pantalla 2026-03-16 080023](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantalla%202026-03-16%20080023.png?width=340&height=478&name=Captura%20de%20pantalla%202026-03-16%20080023.png) ## LNP Analytical Methods Application Note Lipid Nanoparticle Formulation Characterization: Bridging the Gap from R&D to GMP Scale through Robust Analytical Excellence [Download](https://resources.curapath.com/en/lnp-analytical.methods?hsLang=en) ![IL Screenshot](https://resources.curapath.com/hs-fs/hubfs/IL%20Screenshot.png?width=300&height=388&name=IL%20Screenshot.png) ## Ionizable Lipids We now offer a selected list of highly pure ionizable lipids within our catalogue portfolio. [Download](https://resources.curapath.com/en/ionizable-lipids?hsLang=en) ![BioConj Brochure ScreenShot](https://resources.curapath.com/hs-fs/hubfs/BioConj%20Brochure%20ScreenShot.png?width=300&height=388&name=BioConj%20Brochure%20ScreenShot.png) ## Cys Bioconjugation Brochure Optimized Methods Towards Site-selective Cysteine Specific Bioconjugations for Therapeutic Delivery  [Download](https://20205171.hs-sites.com/en/curapath-cys-bioconjugation-brochure?hsLang=en) ![pSar New App note screenshot](https://resources.curapath.com/hs-fs/hubfs/pSar%20New%20App%20note%20screenshot.png?width=300&height=388&name=pSar%20New%20App%20note%20screenshot.png) ## pSar White Paper Polysarcosine (pSar)-a safer, more effective alternative to poly-ethylene glycol (PEG) [Download](https://20205171.hs-sites.com/en/curapath-psar-white-paper-download?hsLang=en) ![Captura de pantalla PNP](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantalla%20PNP.png?width=300&height=388&name=Captura%20de%20pantalla%20PNP.png) ## Polymeric Nanoparticles Case Study Development of a Highly Efficient, Biodegradable, Polymeric, Non-viral Vector (NVV) Platform for Nucleic Acid Delivery [Download](https://20205171.hs-sites.com/en/curapath-pol-nano-case-study?hsLang=en) ![Captura de pantalla 2022-11-23 120532](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantalla%202022-11-23%20120532.png?width=300&height=388&name=Captura%20de%20pantalla%202022-11-23%20120532.png) ## Curapath-Knauer Application Note Development, Screening and Optimization of LNP Formulations using the NanoScaler [Download](https://20205171.hs-sites.com/en/curapath-knauer-app-note?hsLang=en) ![Captura de pantallaVITE](https://resources.curapath.com/hs-fs/hubfs/Captura%20de%20pantallaVITE.png?width=300&height=388&name=Captura%20de%20pantallaVITE.png) ## pSar-VitE General Excipient Case Study Development of PEG-free Excipients for Drug Delivery [Download](https://20205171.hs-sites.com/en/vite-psar-general-excipient?hsLang=en) Want To Learn More? ## Contact our team! You can contact us in the link below or sending an [email](mailto:bd@curapath.com) [Contact Us](https://curapath.com/?page_id=151) ![Lipid-Nanopeptide\_0](https://resources.curapath.com/hs-fs/hubfs/Lipid-Nanopeptide_0.png?width=300&height=300&name=Lipid-Nanopeptide_0.png "Lipid-Nanopeptide_0") ![footer-Logo](https://resources.curapath.com/hubfs/footer-Logo.svg "footer-Logo") [End-to-End Services](https://curapathstg.wpenginepowered.com/end-to-end-services/) [Expertise](https://curapathstg.wpenginepowered.com/expertise/) [Non-Viral Gene Delivery](https://curapathstg.wpenginepowered.com/non-viral-gene-delivery/) [Polymer & Lipid Excipients](https://curapathstg.wpenginepowered.com/polymer-lipid-excipients/) [Analytics & Metrics](https://curapathstg.wpenginepowered.com/analytics-and-metrics/) [Products](https://20205171.hs-sites.com/en/curapath-product-catalog?hsLang=en) [Resources](https://20205171.hs-sites.com/en/curapath-resource-library?hsCtaTracking=fca93105-47df-4ecb-8060-ab8c884fed09%7C49317d58-fe6c-4c70-83cc-d920d6200f8d&hsLang=en) [About Us](https://curapath.com/about-us/) [Contact](https://curapath.com/contact-us/) [Testimonials](https://curapath.com/testimonials/) [News & Events](https://curapath.com/news-events/) [Careers](https://curapath.com/careers/) [Privacy](https://curapath.com/privacy-policy/) [Cookie Policy](https://curapath.com/cookies-policy/) [Legal Notice](https://curapath.com/legal-notice/) US Commercial Offices One Broadway, 14th Floor Cambridge, MA 02142 USA GMP Production Site & Headquarters Av. Benjamin Franklin 19 46980 Paterna, Valencia Spain Innovation & Development Site C/Alexander Graham Bell 6 46980 Paterna, Valencia Spain [![In-White-96@2x-1](https://resources.curapath.com/hs-fs/hubfs/In-White-96@2x-1.png?width=30&height=30&name=In-White-96@2x-1.png "In-White-96@2x-1")](https://www.linkedin.com/company/curapath/) Copyright © 2024 Curapath. All rights reserved.